LYNPARZA
AstraZeneca AB
Trademark Registered: 2016-02-23
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86190624 |
| Registration Number | 4903563 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Wm. Charles Saunders |
| Attorney Docket Number | 102679/US |
| Law Office Assigned | L50 |
| Employee Name | MCPHERSON RAYBURN, SHA |
Timeline
| 2014-02-11 | Application Filed |
| 2015-12-08 | Published for Opposition |
| 2016-02-23 | Location: PUBLICATION AND ISSUE SECTION |
| 2016-02-23 | Status: Live/Registered |
| 2016-02-23 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  AstraZeneca AB |
| Address | Vastra Malarehamnen 9 Södertälje SE SE-15185 |
| Legal Entity Type | Corporation |
| Legal Entity State | SE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for use in oncology |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2014-02-14 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2014-02-24 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2014-05-17 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2014-05-22 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2014-05-22 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2014-05-22 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2014-06-02 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2014-06-02 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2014-06-02 | 9 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2014-06-23 | 10 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2014-06-23 | 11 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2014-06-23 | 12 GNS3 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2014-09-04 | 13 ERSI I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2014-09-04 | 14 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2014-09-04 | 15 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2014-09-19 | 16 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2014-09-19 | 17 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2014-09-19 | 18 GNS3 O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2014-11-04 | 19 DOCK D:Assigned to Examiner |
| ASSIGNED TO LIE | 2015-04-10 | 20 ALIE A:Allowance for Publication |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2015-04-13 | 21 RCCK S: |
| SUSPENSION INQUIRY WRITTEN | 2015-04-20 | 22 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2015-04-20 | 23 GNSI S: |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2015-04-20 | 24 GNS2 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2015-10-05 | 25 ERSI I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-10-13 | 26 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-10-13 | 27 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-10-29 | 28 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2015-11-04 | 29 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2015-11-18 | 30 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2015-12-08 | 31 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2015-12-08 | 32 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2016-02-23 | 33 R.PR A:Allowance for Publication |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2021-02-23 | 34 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2021-03-04 | 35 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2021-07-14 | 36 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2021-07-14 | 37 C15A O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2021-07-14 | 38 NA85 E:E-Mail |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-07-22 | 39 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-07-22 | 40 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-07-22 | 41 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2021-07-22 | 42 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-07-22 | 43 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-07-22 | 44 CHAN I:Incoming Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 LYNPARZA 86476170 4991136 Live/Registered |
AstraZeneca AB 2014-12-10 |
 LYNPARZA 86190624 4903563 Live/Registered |
AstraZeneca AB 2014-02-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 